SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-11-000082
Filing Date
2011-11-07
Accepted
2011-11-07 17:18:05
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 form10q3q2011.htm 10-Q 700183
2 CEOCERT exhibit311.htm EX-31.1 16561
3 CFOCERT exhibit312.htm EX-32.1 16570
4 CEOCERT exhibit321.htm EX-32.1 6997
5 CFOCERT exhibit322.htm EX-32.2 7565
  Complete submission text file 0001008848-11-000082.txt   4214509

Data Files

Seq Description Document Type Size
6 acor-20110930.xml EX-101.INS 554696
7 acor-20110930.xsd EX-101.SCH 30610
8 acor-20110930_cal.xml EX-101.CAL 55607
9 acor-20110930_def.xml EX-101.DEF 96300
10 acor-20110930_lab.xml EX-101.LAB 445806
11 acor-20110930_pre.xml EX-101.PRE 243774
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 111185495
SIC: 2836 Biological Products, (No Diagnostic Substances)